Frédéric Martin

Frédéric Martin is an experienced leader in the pharmaceutical industry, currently serving as Vice President and Global Medicine Commercialisation Lead for Oncology at GSK since January 2020, where responsibilities include establishing the Oncology Business Unit in France and integrating the Tesaro Commercial Team post-acquisition. Previously, Martin held multiple roles at Amgen from May 2009 to January 2020, culminating in the position of Director of the Onco-Hematology Business Unit, which involved oversight of sales and marketing teams and the commercialization of five medicines. Early in Martin's career, consulting at ZS emphasized sales and marketing strategy for pharmaceutical and biotech companies. Educational qualifications include a Master of Science in Electrical and Computer Engineering from Georgia Institute of Technology and an engineering degree from CentraleSupélec.